News
09-12-2008, 07:10 AM
The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix's sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated
More... (http://www.medicalnewstoday.com/articles/121256.php)
More... (http://www.medicalnewstoday.com/articles/121256.php)